A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease

NCT03136991 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DRUG: AZD4831
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]